# Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers

> **NCT00318214** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 16 (actual)

## Conditions studied

- Foot Ulcer, Diabetic
- Diabetes Complications

## Interventions

- **DRUG:** MRE0094
- **DRUG:** Vehicle gel

## Key facts

- **NCT ID:** NCT00318214
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** The study had poor enrollment with only 16 patients randomized across 19 study centers over an 18-month period.
- **Last updated:** 2012-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00318214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00318214, "Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00318214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*